Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

0.56USD
24 Dec 2014
Price Change (% chg)

$-0.00 (-0.86%)
Prev Close
$0.56
Open
$0.57
Day's High
$0.57
Day's Low
$0.56
Volume
33,697
Avg. Vol
244,884
52-wk High
$1.56
52-wk Low
$0.35

ACST.O

Chart for ACST.O

About

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)

Overall

Beta: 0.49
Market Cap (Mil.): $68.01
Shares Outstanding (Mil.): 106.26
Dividend: --
Yield (%): --

Financials

  ACST.O Industry Sector
P/E (TTM): -- 38.24 38.63
EPS (TTM): -0.09 -- --
ROI: -28.76 19.00 18.26
ROE: -32.42 19.75 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks